1990至2021年糖尿病视网膜病变相关盲与视力损失的全球时间趋势:年龄-时期-队列分析及1型与2型糖尿病的贡献
本研究基于GBD 2021数据,采用年龄-时期-队列分析,区分1型与2型糖尿病,评估糖尿病视网膜病变相关盲与视力损失的全球趋势。结果显示,全球年龄标化患病率从1990年的48.8/10万升至2021年的67.3/10万,1型糖尿病相关年龄标化患病率从1.8/10万小幅降至1.7/10万;高SDI组相对增幅最大(45.8%)。2型糖尿病观察到不利的时期和队列效应,而1型糖尿病未观察到。
要点
- 全球糖尿病相关盲与视力损失年龄标化患病率从1990年48.8/10万升至2021年67.3/10万。
- 1型糖尿病相关年龄标化患病率从1.8/10万小幅降至1.7/10万,高SDI组相对增幅最大(45.8%)。
- 2型糖尿病存在不利的时期和队列效应,1型糖尿病未观察到;高-中SDI和中SDI组时期与队列效应增幅最显著。
核心结论
- 近几十年来,1型与2型糖尿病相关盲与视力损失的年龄标化患病率、时期和队列效应在不同SDI类别间呈现显著不同的趋势。
研究设计与样本
- 基于GBD 2021研究的二次分析,使用不同SDI类别下糖尿病视网膜病变所致盲与视力损失的估计数据。
- 分析了年龄标化患病率、相对百分比变化、净漂移和局部漂移。
主要发现
- 全球糖尿病相关盲与视力损失年龄标化患病率从1990年48.8/10万升至2021年67.3/10万。
- 1型糖尿病相关年龄标化患病率从1.8/10万小幅降至1.7/10万。
- 高SDI组相对增幅最大,为45.8%。
- 1型糖尿病中,低-中SDI和低SDI组相关年龄标化患病率下降更明显。
- 各SDI组年龄标化患病率随年龄增长而增加,但1型糖尿病不如2型糖尿病明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The current study aims to investigate how age, period and cohort effects have shaped the patterns of diabetic retinopathy-related vision loss globally, distinguishing between loss associated with type 1 versus 2 diabetes. METHODS: A secondary analysis of data from the Global Burden of Disease (GBD) 2021 study was conducted by using estimates of blindness and vision loss due to DR across different socio-demographic index (SDI) categories. Age-standardised prevalence rates, relative percentage changes, net drift and local drift were analysed. FINDINGS: Globally, age-standardised prevalence (ASPR) of diabetes-related blindness and vision loss rose from 48.8 per 100 000 in 1990 to 67.3 per 100 000 in 2021, with type 1 diabetes-related blindness and vision loss ASPR showing a modest decrease (from 1.8 to 1.7 per 100 000). The highest relative increase was recorded in the high SDI group (45.8%). For Type 1 diabetes, low-middle and low SDI groups exhibited more pronounced declines in associated ASPR. Increasing ASPR with advancing age was consistent across SDI groups though less pronounced for type 1 than type 2 diabetes. Unfavourable period and cohort effects were observed for type 2 but not type 1-related blindness and vision loss risk. High-middle SDI and middle SDI groups showed the most notable increase in period and cohort effect, whereas low-middle and low SDI groups experienced favourable period and cohort risks during the study duration. CONCLUSIONS: Substantially different trends were observed for ASPR, period and cohort effects in recent decades for type 1 versus type 2 diabetes across different SDI.
引用
- Guan Z, Li Y, Li Y, et al. Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes. Br J Ophthalmol. 2026. PMID: 42476825. doi:10.1136/bjo-2025-328581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。